Center for Cancer Research Patient Travel

癌症研究中心患者旅行

• 批准号: 10262795
• 负责人: Cheryl Royce
• 金额: $ 750.8万
• 依托单位: DIVISION OF BASIC SCIENCES - NCI
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10262795
• 关键词: CCR; Cancer Intervention; Clinical; Clinical Research; Clinical Research Protocols; Clinical Trials; Detection; Development; Diagnosis; Disease; Enrollment; Funding; Goals; Incidence; Malignant Neoplasms; Maryland; Methods; Mission; Molecular; Monitor; NCI Center for Cancer Research; Participant; Patients; Pre-Clinical Model; Screening for cancer; Transportation; Travel; United States National Institutes of Health; base; cancer prevention; clinical center; cost; named group; new technology; novel; novel strategies; novel therapeutic intervention; outcome forecast; translational clinical trial

The clinical research mission of the CCR is as follows: * Conduct hypothesis-based translational clinical trials that evaluate new therapeutic approaches * Develop novel approaches to early cancer detection and prevention * Develop and deliver novel technologies for molecular characterization, detection, diagnosis, and monitoring of cancer * Emphasize understudied diseases and cancers with increasing incidence, poor prognosis, or involving special populations * Develop better preclinical models and methods to expedite development of novel interventions for cancer. To accomplish these goals CCR develops and carries out clinical trials that are open to all U.S. citizens. Patients enrolled on clinical trials are treated at the NIH Clinical Center in Bethesda, Maryland and are reimbursed for their travel, lodging and meals.

CCR的临床研究使命如下：* 开展基于假设的转化临床试验，评估新的治疗方法 * 开发早期癌症检测和预防的新方法 * 开发和提供用于癌症分子表征、检测、诊断和监测的新技术 * 强调研究不足的疾病和发病率增加、预后不良的癌症，* 开发更好的临床前模型和方法，以加快癌症新干预措施的开发。为了实现这些目标，CCR开发并开展了向所有美国公民开放的临床试验。参加临床试验的患者在马里兰州贝塞斯达的NIH临床中心接受治疗，并报销他们的旅行、住宿和膳食。